注册已开启

查看我的门票

已截止
活动简介

In collaboration with the Carolinas, Georgia, Florida Chapter of the American Society of Hypertension, Continuing Education Company (CEC) are pleased to offer the 22nd Annual Medical Conference on Hypertension, Diabetes, and Dyslipidemia. This three day intensive conference, held on June 22-24, 2018 in Charleston, South Carolina, has been endorsed by the American Society of Hypertension (ASH), and Southeast Lipid Association.

Over the past several years controversies in the appropriate level of Hemoglobin A1C, BP, and LDL-Cholesterol for outcome improvement continue to occur in Type 2 diabetes, Hypertension, and Dyslipidemia, respectively. Despite the results from the ACCORD, VADT, and ADVANCE studies suggesting the benefits on reducing macrovascular disease with a more intensive strategy for A1C reduction remains unclear, individualized A1C targets for those with newly diagnosed diabetes compared to those with long standing disease are often recommended. In addition, controversy continues to exist in cholesterol control as recent guidelines suggest that one should decide on the intensity of statin-based therapy for outcome improvement in those at risk for or with established ASCVD rather than a specific goal of LDL-cholesterol reduction. Finally, the recent SPRINT trial has suggested that lower targets for BP reduction than ever achieved before can and should be achieved in high-risk adults with hypertension.

This conference will address these and other issues confronting the clinician who treats challenging patients with diabetes, hypertension, and dyslipidemia. The participant will learn the most current information on these issues and will be able to apply these important clinical principles back to their everyday practice to improve the care of their patients.

留言
验证码 看不清楚,更换一张
全部留言
重要日期
  • 会议日期

    06月22日

    2018

    06月24日

    2018

  • 06月24日 2018

    注册截止日期

移动端
在手机上打开
小程序
打开微信小程序
客服
扫码或点此咨询